Shift in perspective. In this episode of your ONCOmmunity podcast, we will discuss the clinical utility of large panels from the point of view of two oncologists: Dr. Benedikt Westphalen, medical director of precision oncology, medical clinic 3 LMU at the Comprehensive Cancer Centre in Munich, and Dr. Thomas Winder, head of gastroenterology, haematology, oncology and infectiology at the Feldkirch Regional Hospital in Austria and director of the Swiss Tumour Molecular Institute in Zurich.
Comprehensive molecular testing is becoming more and more affordable and available. There are challenges remaining, but both oncologists will come back to cases where extensive genomic tests translated into promising treatment approaches for cancer patients and will consider future changes in the clinical decision-making process.
“With the increase of molecular tests, there has also been a desire to be able to discuss these test results in interdisciplinary expert panels. We need cross-sectoral networks for precision oncology so that physicians in private practice and at smaller hospitals can benefit from a wide range of modern, molecular oncology”, they say about the importance of bundling knowledge and harmonizing clinical findings.